Shares of Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$12.06 and traded as low as C$11.40. Cipher Pharmaceuticals shares last traded at C$11.47, with a volume of 24,879 shares traded.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group set a C$12.50 price objective on Cipher Pharmaceuticals and gave the stock a "hold" rating in a report on Monday, April 7th.
Check Out Our Latest Stock Analysis on CPH
Cipher Pharmaceuticals Price Performance
The company has a market capitalization of C$234.11 million, a PE ratio of 14.40 and a beta of 1.20. The company has a current ratio of 2.00, a quick ratio of 2.67 and a debt-to-equity ratio of 41.22. The company's 50 day moving average price is C$12.03 and its 200-day moving average price is C$13.66.
Insiders Place Their Bets
In related news, Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total transaction of C$47,215.00. 42.00% of the stock is currently owned by insiders.
Cipher Pharmaceuticals Company Profile
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Featured Stories
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
